Service Organisation Top 10 Priorities (priority setting in association with the JLA)
A final workshop was held 9th July 2021 and brought together patients and healthcare professionals to jointly agree a priority list for vascular service research.
- How can regional vascular services best be organised and delivered to provide the best outcomes and experience for vascular patients?
- What can be done to ensure that GPs and other healthcare staff have a better understanding of vascular disease?
- What can be done to make sure that people with vascular problems get to see the most appropriate professionals as quickly as possible?
- What is the best way to help people with lifestyle changes such as diet, smoking cessation and exercise?
- How can awareness of vascular disease be improved amongst people with vascular symptoms and the general public?
- What can be done to improve communication between healthcare professionals and people with vascular disease?
- What can be done to make sure that everyone involved in treating vascular patients communicates better with each other?
- New and emerging technologies; how should they introduced and evaluated?
- What can be done to make sure that everyone gets fair and equal access to the best vascular treatment, regardless of individual characteristics?
- How can better treatments be developed for vascular conditions that do not require major operations?
The following questions were also discussed and put in order of priority at the workshop:
- How can pre-op risk assessment be optimised and fitness improved in vascular patients?
- Which tests are most useful for the diagnosis of vascular disease and where should they be carried out?
- How can specialist vascular nurses improve the experience for people with vascular disease?
- How can length of hospital stay for vascular patients be reduced safely?
- What can be done to make sure that the outcome measures used for vascular services address the things that matter most to people with vascular disease?
- How can the way people with vascular disease be better informed about treatment options, so that they can take a greater part in shared decision-making?
- Should current screening programmes look for other vascular conditions?
- What can be done to improve patient and public engagement and understanding of research?